SEC Form 4 · accession 0001179110-15-002335
Apollo Endosurgery, Inc. · APEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dario A. Paggiarino
Officer — Sr VP & Chief Dev. Officer
Period of report
Feb 9, 2015
Accepted (ET)
Feb 11, 2015 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001251769
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.86 | Feb 9, 2015 | A | 50,000 | A | — | Feb 19, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F125% of the option shares vest and become exercisable one year following the date of grant (Feburary 9, 2015) and the remaining shares will vest and become exercisable in 36 equal monthly installments thereafter.